@EtihadHelp Hi, I just try to book a flight for 2 persons from Auckland to Munich on the 26th of March. However, the booking was obviously not completed and I've been asked to contact you.
👆Urgent! Until Wednesday, 5 pm: EU Commission calls for applications from #startups and #SMEs with innovative solutions to tackle #coronavirus outbreak. #funding@EU_Commission https://t.co/unTRvrzSKZ
Not easy to explain antibody research in a simple phrase!
(My grandma actually believes that I am working in a pharmacy)
Read more about us and our spin-off #Eximmium in the following interview (only available in German):
https://t.co/XiKy3YXD5q
@eximmium@HelmholtzMunich
Gar nicht so einfach, einem Laien unsere Arbeit auf verständliche Art und Weise zu erklären!
Erfahrt in diesem Interview mehr über uns und unsere Ziele 💡:
#CancerResearch#startuplife@helmholtz_en@HelmholtzMunich
https://t.co/NeoaQZXqgc
Happy Women in Science Day everyone 👩🔬! Let's encourage more girls and young women to explore opportunities in STEM fields. We need more women in science to step forward!
#WomenInScience
Today we join @UNESCO celebrating #WomenInScience!
Whether she wants to study nanoparticles, solve the climate crisis, or go to space, let her study, let her work, let
her lead.
Her curious mind is needed for a better future.
Today is #WorldCancerDay
DeepMACT is an AI-based technology to detect cancer metastasis and drug targeting at the cellular level in whole mouse body. Thereby, it can accelerate development of effective cancer treatments.
#AI#cancer#machinelearning
https://t.co/KJLGjiye49
Congrats to Ali Ertürk and his lab on this outstanding publication 🥳! We are very happy that we could contribute to this amazing work. @erturklab @ReinhardZeidler
Congrats to Ali Ertürk and his lab on this outstanding publication 🥳! We are very happy that we could contribute to this amazing work. @erturklab @ReinhardZeidler
I am very excited to share our paper on deep learning-based study of cancer metastasis and drug targeting, just out at Cell.
Turn on the SOUND😀& hopefully enjoy the animation.
More details are below 👇🏼
@CellPressNews@CellCellPress#AI#Cancer
https://t.co/KJLGjiye49
It was a great #BES2019! Thanks to all participants, speakers, exhibitors, startups, sponsors and many more. A big thank also to #translaTUM@TU_Muenchen for the great location. Have a save trip home and see you in 2021! We are curious which #startup will be founded by then.😉
Amazing news! The role of hypoxia in tumor development has been underestimated for a long time. It's a good thing that we have several antibodies in development that target hypoxia-induced molecules :-) #hypoxia#NobelPrize2019#welovescience
BREAKING NEWS:
The 2019 #NobelPrize in Physiology or Medicine has been awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza “for their discoveries of how cells sense and adapt to oxygen availability.”
Here comes our new logo :-)! 👏🍾 Some say it looks like an angel... For us it's a modern version of an antibody and an extracellular vesicle! But cancer therapy may also sometimes need a bit of help from a guardian angel 😇
#newlogo#startup#antibody#cancertherapy
We are already excited to present #Eximmium at the BioEntrepreneurship Summit 2019 in Munich! Looking forward to fruitful discussions and great talks & pitches.